ABCB1 and ovarian carcinoma: Demonstration of clinical relevance for ABCB1 upregulation on chemoresistance in ovarian cancer has been inconsistent; however, recent reports highlight the importance of ABCB1-overexpression in the treatment of recurrent ovarian cancer [55, 56].